Clinical Trials Directory

Trials / Unknown

UnknownNCT05838118

Washed Microbiota Transplantation (WMT) for Chronic Kidney Disease (CKD)

Washed Microbiota Transplantation (WMT) for Chronic Kidney Disease (CKD): a Open Label, Multicenter Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
The Second Hospital of Nanjing Medical University · Academic / Other
Sex
All
Age
16 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Wahsed microbiota transplantation (WMT) is a novel and promising therapeutic method for Chronic Kidney Disease (CKD). This clinical trail aims to evaluate the efficacy and safety of WMT in the treatment of CKD.

Detailed description

Although the therapeutic methods progress, numerous patients with Chronic Kidney Disease (CKD) can not avoid the clinical outcome of end-stage renal disease. CKD still needs novel treatment to significantly improve the survival quality of the patients. Gut microbiota has been verified to have relation with immunity. Immunity plays a role in many chronic kidney disease, such as IgA nephropathy, membranous nephropathy and so on. Fecal microbiota transplantation (FMT) is a novel, safe, convenient therapeutic treatment which transplant gut microbiota from donor to patient to rebuild a gut microecology. This study aims to evaluate the efficacy and safety of FMT in CKD patients. Patients in this study will undergo three times WMT. The primary outcome measure was the clinical remission efficacy rate in the CKD patients. The secondary outcome measure was the safety of WMT in CKD.

Conditions

Interventions

TypeNameDescription
DRUGFecal Microbiota TransplantationBiologically active human fecal fluid (donor stool) is provided in fluid form.
OTHERStandard of Care for Chronic Kidney DiseasePatients accepted oral drug or dialytic therapy like they used to be to treat CKD.

Timeline

Start date
2023-04-20
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2023-05-01
Last updated
2023-05-01

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05838118. Inclusion in this directory is not an endorsement.